Evaluating the prevalence of nephrolithiasis in kidney transplant recipients admitted to Imam Khomeini Hospital in Urmia in 2018-2019.
Archives of Men's Health,
Vol. 6 No. 1 (2022),
1 January 2022
,
Page e17
https://doi.org/10.22037/mhj.v6i1.40182
Abstract
Introduction: Nephrolithiasis is almost common urological disease in the world that involves near 10 percent of adult population. Several researches are demonstrative of increasing prevalence and incidence of nephrolithiasis in industrial societies, because of changing the life style, food regimen and obesity that is very common. Though prevalence of nephrolithiasis in grafted kidney is rare, but because of importance of effects after grafting or graft rejection is needed to attention and study. Methods: In this research incidence of nephrolithiasis and the difference of it before and after the kidney transplantation in graft receiver of kidney in Urmia Imam Khomeini hospital for two years in 2018-2019 has studied, and followed after one year. Relation between age, education level, and sex have been evaluated too. Results: In this study 32 receiver of kidney transplant have been studied. Among this 32 patient 3 cases had nephrolithiasis after transplantation that they didn’t have any history of nephrolithiasis, And 3 cases had history of nephrolithiasis that after transplantation no kidney stone was seen (P<0.05).Higher prevalence of nephrolithiasis was significantly related to higher level of education (p<0.05), but age and sex was not significantly different in two groups (P>0.05). Conclusion: It’s concluded that the main reason of nephrolithiasis is the kidney organ that can make stone in the new body, and level of education was higher in the nephrolithiasis group (affected or have the history) than the healthy group.
- Kidney transplantation
- Effects
- Nephrolithiasis
How to Cite
References
Scales CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5.
Kim Hh, Jo MK, Kwak C, Park SK, Yoo KY, Kang D, et al. Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology. 2002 Apr;59(4):517-21.
3-Hess B. Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi. Ther Umsch 2003; 60:79-87.
4-Dalen N, Hjern B. Bone mineral content in patients with primary hyperparathyroidism without radiological evidences of skeletal changes. Acta Endocrinol 1974; 75: 297-304.
5- Johri N, Cooper B, Robertson W, Choong S, Rickards D, Unwin R. An update and practical guide to renal stone management. Nephron Clin Pract. 2010;116(3):c159-71.
6- Safarinejad MR. Adult urolithiasis in a population-based study in Iran: prevalence, incidence and associated risk factors. Urol Res 2007; 35: 73-82 [Persian].
7- Rafiei H, Malekpoor F, Amiri M, Rahimi Madiseh M, Lalegani H. Kidney stone development among Older Adults in Iran. J Indian Acad Geriatr 2014; 10: 10-3.
8-Li D, Liu J, Ren J, Yan L, Liu H, Xu Z. Meta-analysis of the urokinase gene 3'-UTR T/C polymorphism and susceptibility to urolithiasis. Biomed Rep 2013 May; 1 (3): 369-74.
9- Yuan HJ, Yang DD, Cui YS, Men CP, Gao ZL, Shi L, et al. Minimally invasive treatment of renal transplant nephrolithiasis. World J Urol. 2015 Dec;33(12):2079-85.
10-Porena M, Guiggi P, Micheli C. Prevention of stone disease. Urol Int. 2007;79 Suppl 1:37-46.
11- Muhari-Stark E, Burckart GJ. Glomerular Filtration Rate Estimation Formulas for Pediatric and Neonatal Use. J Pediatr Pharmacol Ther. 2018 Nov-Dec;23(6):424-431
12- Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017 Mar 25;389(10075):1238-52.
13- Hashmi MF, Benjamin O, Lappin SL. End-Stage Renal Disease. 2022 Nov 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 29763036.
14- Rezaee-Zavareh MS, Ajudani R, Ramezani Binabaj M, Heydari F, Einollahi B. Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival. Int J Organ Transplant Med. 2015;6(3):114-8.
15- Friedersdorff F, El-Bandar N, Busch J, Erber B, Miller K, Fuller TF, et al. Urolithiasis in Renal Allografts: Complications and Outcomes. Exp Clin Transplant. 2017;15(2):164-70.
16- Lashay A, Masoumi N, Dehghani M, Nakhaei M. Studying the Predictability of the Presence of Ureteral Stones in Patients with Negative Sonographic Findings ,J Ardabil Uni Med sci 2018, Vol. 18, No. 2, Pages 154-16014-Praus F, Schonthaler M. Modifiable and non-modifiable risk factors for urolithiasis. Urologe A. 2019;58(11):1281.
- Abstract Viewed: 312 times
- pdf Downloaded: 209 times